Considerable evidence has revealed that SLC27A2 is related to various metabolic disorders or diseases, such as lipotoxicity, oxidative stress and energy production, nonalcoholic fatty liver disease (NAFLD), type 2 diabetes mellitus (T2DM), kidney fibrosis, and cancers [33, 34]. This evidence concerns the gene SLC27A2 and diabetes mellitus.